Polymyalgia rheumatica

Literatur

• 1 Ayoub W T, Franklin C M, Torretti D. Polymyalgia reumatica. Duration of therapy and long-term outcome.  Am J Med. 1985;  79 309-315
  Google Scholar
• 2 Behn A R, Perera T, Myles A B. Polymyalgia rheumatica and corticosteroids: how much for how long?.  Ann Rheum Dis. 1983;  42 374-378
  Google Scholar
• 3 Bird H A, Esselinckx W, Dixon A S, Mowat A G, Wood P H. An evaluation of criteria for polymyalgia rheumatica.  Ann Rheum Dis. 1979;  38 434-439
  Google Scholar
• 4 Bird H A, Leeb B F, Montecucco C M. et al . A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica.  Ann Rheum Dis. 2005;  64 626-629
  Google Scholar
• 5 Blockmans D, de Ceuninck L, Vanderschueren S. et al . Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.  Arthritis Rheum. 2006;  55 131-137
  Google Scholar
• 6 Cantini F, Salvarani C, Niccoli L. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome: a prospective follow-up and magnetic resonance imaging study.  Ann Rheum Dis. 1999;  58 230-236
  Google Scholar
• 7 Caporali R, Cimmino M, Ferracioloi G. et al . Prednisone plus methotrexate for polymyalgia rheumatica. A randomized, double-blind, placebo-controlled trial.  Ann Intern Med. 2004;  141 493-500
  Google Scholar
• 8 Chuang T Y, Hunder G G, Ilstrup D M, Kurland L T. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.  Ann Intern Med. 1982;  97 672-680
  Google Scholar
• 9 Cimmino M A, Salvarani C, Macchioni P, Gerli R. et al . Systemic Vasculitis Study Group of the Italian Society for Rheumatology. Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids.  Clin Exp Rheumatol. 2008;  26 395-400
  Google Scholar
• 10 Cutolo M, Montecucco C M, Cavagna L. et al . Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis.  Ann Rheum Dis. 2006;  65 1438-1443
  Google Scholar
• 11 Dasgupta B, Hutchings A, Matteson E L. Polymyalgia rheumatica: the mess we are now in and what we need to do about it.  Arthritis Rheum. 2006;  55 518-520
  Google Scholar
• 12 Dasgupta B, Salvarani C, Schirmer M. et al . Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey.  J Rheumatol. 2008;  35 270-277
  Google Scholar
• 13 Font R L, Prabhakaran C. Histologic parameters helpful to recognize steroid-treated temporal arteritis. An analysis of thirty-five cases.  Br J Ophthalmol. 2007;  91 204-209
  Google Scholar
• 14 Gabriel S, Sunku J, Salvarani C. et al . Adverse outcomes and anti-inflammatory therapy among patients with polymyalgia rheumatica.  Arthritis Rheum. 1997;  40 1873-1878
  Google Scholar
• 15 Hellmich B, Gross W L. Polymyalgia rheumatica. Myalgisches Syndrom oder okkulte Vaskulitis?.  Internist. 2005;  46 1233-1244
  Google Scholar
• 16 Hoffman G S, Cid M C, Rendt-Zagar K E. et al . Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis.  Ann Intern Med. 2007;  146 621-630
  Google Scholar
• 17 Krüger K. Infliximab bei Riesenzellarteriitis und Polymyalgia rheumatica ineffektiv.  Z Rheumatol. 2007;  66 536-537
  Google Scholar
• 18 Kyle V, Hazleman B L. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimes in the first 2 months.  Ann Rheum Dis. 1989;  48 658-661
  Google Scholar
• 19 Lopez-Hoyos M, de Ruiz Alegria C, Blanco R. et al . Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica.  Rheumatology. 2004;  4 655-657
  Google Scholar
• 20 Maradit-Kremers H M, Reinalda M S, Crowson C S. et al . Relapse in a population based cohort of patients with polymyalgia rheumatica.  J Rheumatol. 2005;  32 65-73
  Google Scholar
• 21 Narváez J, Nolla-Solé J M, Narváez J A, Clavaguera M T, Valverde-García J, Roig-Escofet D. Musculoskeletal manifestations in polymyalgia rheumatica and temporal arteritis.  Ann Rheum Dis. 2001;  60 1060-1063
  Google Scholar
• 22 Narváez J, Narváez J A, Nolla J M. et al . Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis.  Rheumatology. 2005;  44 479-483
  Google Scholar
• 23 Olivieri I, Garcia-Porrua C, Padula A. et al . Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases.  Rheumatol Int. 2007;  27 927-933
  Google Scholar
• 24 Salvarani C, Cantini F, Boiardi L, Hunder G G. Polymyalgia rheumatica and giant-cell arteritis.  N Engl J Med. 2002;  347 261-271
  Google Scholar
• 25 Salvarani C, Macchioni P L, Manzini C. et al . Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica.  Ann Intern Med. 2007;  146 631-639
  Google Scholar
• 26 Smeeth L, Cook C, Hall A J. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990 to 2001.  Ann Rheum Dis. 2006;  65 1093-1098
  Google Scholar
• 27 Smetana G W, Shmerling R H. Does this patient have temporal arteritis?.  JAMA. 2002;  287 92-101
  Google Scholar
• 28 Schmidt W A, Gromnica-Ihle E. Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler sonography of the temporal arteries.  Rheumatology. 2002;  41 46-52
  Google Scholar
• 29 Schmidt W A, Gromnica-Ihle E, Caspary L, Stiegler H. Polymyalgia rheumatica und Riesenzellarteriitis (Arteriitis temporalis). In: Dierkesmann R, Fleig WE, Heidrich H, Heimpel H, Koch KM, Meyer J, Müller OA, Specker C (Hrsg.) Rationelle Diagnostik und Therapie in der Inneren Medizin: Leitlinien. Elsevier. Urban & Fischer 2006
  Google Scholar
• 30 Weyand C M, Goronzy J J. Giant-cell arteritis and polymyalgia rheumatica.  Ann Intern Med. 2003;  139 505-515
  Google Scholar

Prof. Dr. med. Elisabeth Märker-Hermann

Klinik Innere Medizin IV (Rheumatologie, klinische Immunologie und Nephrologie), HSK Dr. Horst Schmidt Klinik GmbH

Ludwig Erhard Str. 100

D-65199 Wiesbaden

Phone: 0611/436-445

Fax: 0611/436-464

Email: Elisabeth.Maerker-Hermann@HSK-Wiesbaden.de